FDA Investigator Joseph R Lambert

Joseph R Lambert has inspections in 6 countries as of 14 Nov 2023. Joseph R Lambert has collaborated with a combinined 5415 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
176
Last Inspection Date:
14 Nov 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
India, United States of America, Italy, Switzerland, Canada, China
Co-Investigator(s):
A Williams, Adree N Anderson, Alan E Mehl, Alan L Truong, Alan M Barker, Alysia C Alger, Alysia C Investigator, Amy E Devine, Ana Paulap Sandee, Andrew A Hoopes, Andrew K Schaal, Ann Marie Montemurro, Anthony J Ladner, Anthony R Bucks, Aqualia L Nelson, Arsen Karapetyan, Ashley A Mutawakkil, Avery J Dennis, Barbara I Rogolsky, Barbara J Ragolsky, Barbara Janine Breithaupt, Barbara L Rogolsky, Bei Y He, Brandy N Lepage, Brenda C Hamilton, Brent M Dehaan, Brent T Hall, Brett R Havranek, Brian D Nicholson, Bridgette M Mattern, Brittany D Phillips, Brittany D Terhar, Bryan S Roddy, Candace S Tucker, Carl A Huffman, III, Carl J Montgomery, Carmen Y Fisher, Caryn M Mcnab, Chad W Rice, Charles D Brown, Charles M Edwards, Chilton L Ng, Chris A Sack, Christine A Harman, PhD, Christopher D Leach, Christopher T Middendorf, Clifford F Long, Cody D Rickman, Cody J Alley, Collins M Mason, Constantin Y Philopoulos, Courtney R Bratina, Cynthia Jim, CSO, Cynthia L Evitt, Cynthia M Godeau, Cynthia M Goudeau, Damaris Y Hernandez, Dana D Carter, SR DDS, Danial S Hutchison, Daniel R Hurt, Darrah, David A Foran, David F Graham, David J Eide, David L Miser, Dawn C Olenjack, Diana K Krepel, Diane L Raccasi, Dina K West, Don Hardy, Donald L Myers, Douglas M Monroe, Dr. Abhijit Raha, PhD, Dwight D Ferguson, Edward E Lockwood (EEL), Emilie E Kahn, Eric C Fox, Eric C Nielsen, Eric L Dong, BS, Eric M Mueller, PharmD, Eric M Padgett, Eric Nielson, Eric T Huebler, Erika V Butler, Erin C Dugan, Farhana Khan, Felix Maldonado, George Ivan Wey, Gretchen Lf Trendel, Gwyn G Dickinson, Heath W Cartwright, Hector A Carrero, Helen Y Saccone, Huffmanc, Ingrid Y Johnson, Ismael Garibay, Ismael Oera Lv, Ismael Olvera, IV, Ivis Lnegron Torres, J Michael Cannon, PhD, Jacob G Lutz, Jacqueline Mdiaz Albertine, Jacqueline Mdiaz Albertini, James D Planchon, James I Giefer, James J Houlihan, James K Rice, James P Mcreavey, Jane E Nelson, Janesa A Licorish, Janet B Abt, Janete A Eaker, Janete A Oliveira, Jazmine N Still, Jeffery A Hangartner, Jeffrey B Moody, Jennifer Cahill, Jennifer T Szymanski, Jenny Aagila Sefen, Jessica E Hensley, Jessica L Peterson, Jessica L Pressley, Jill J Tillman, Jimmie L Weigand, John A Iwen, John A Marchin, Johnson, Johnsont, Jonathan R Campos, Joohi Castelvetere, Jose Acruz Gonzalez, Jose Alopez Rubet, Joseph J Vannelli, Julie N Vosilus, Jyoti B Patel, PhD, Kamara Mo, Kara L Cooper, Kara L Roden, Karen C Daugherty, Karen M Montgomery (KMM), Katherine M Taylor, Kathleen B Swat, Kathleen J Close, Kathleen J Klier, Kathryn A Bushur, Kellia N Hicks, Kelly A Lynch, Kelly K Nachtigal, Ken L Bowers, Kenneth D Bland, Kethleen J Klier, Kevin A Beavers, Kevin D Kallander, Kevin P Foley, Kham Phommachanh, Kristi B Panzer, Lane V Christensen, PhD, Latonya M Mitchell, Laura Fontan, MS, Laura S Huffman, LCDR Matthew J Morrison, Linda K Cline, Linda R Kuchenthal, Linhart, Lionell L Thomas, Lisa L Flores, Lisa L Gilliam, Lori A Gioia, Louis S Chen, Marc A Jackson, Jr, Marcellinus D Dordunoo, Marcus F Yambot, Margaret A Smithers, Marion D Wimberly, Jr, Marlene G Swider, Martin J Kurek, Mary K Concannon, Matthew B Casale, Matthew M Schuckmann, Matthew R Sleeter, Meisha R Sampson, Meisha Waters, Melinda L Rice, Melissa D Ray, Melva J Palmer, Merril E Racke, Merril Racke, PhD, Michael A Feingold, Michael C Zubelewicz, Michael F Skelly, PhD, Michael Shanks, MS, Michael V Hamilton, Michele L Obert, Michele Perry Williams, Mihaly S Ligmond, Mindy M Chou, Minerva Rogers, Mohsen Rajabi Abhari, FDA, Monica M Mcclure, Mra M Barbosar, Nadine J Nanko, Nancy G Schmidt, Neal L Adams, Nia K Walker, Nicole E Knowlton, Nicole J Clausen, Nicole J Conklin, Nilufer M Tampal, PhD, Noreen Muniz, Norman K Starks, Omotunde O Osunsanmi, Paige E Shelborne, Paige E Wilson, Pal S Mayasandra, Pamela L Vega, Patricia L Payne, Patrick L Wisor, Paul A Bonneau, Paul Klug, Paul Mouris, Paula A Trost, Peng Zhou, Penny H Mccarver, Pratik S Upadhyay, DDC, Qin Xu, Ralph H Vocque, Rashonda N Rucker, Regina T Brown, Rendall E Barfoot, Richard L Rutherford, Rita K Kabaso, Robert J Ham, Robert R Wilson, Robin E Hayes, Robin K Reel, Rodney D Combs, Roger F Zabinski, Ryan S Martin, Saleem A Akhtar, Samantha J Bradley, Samuel K Gibbons, Jr, Sandra A Boyd, Sarah E Morris, Sarah E Rhoades, Scott A Golladay, Scott A Jepson, Scott N Lim, Scott T Ballard, Shafiq S Ahadi, Shanna R Haden, Shannan B Beisser, Sharon K Thoma, PharmD, Shaun M Olson, Shaun M Stracener, Shawn B Johnson, Sheri L Stephenson, Sherry G Bous, Shirley J Berryman, Shirshendu K Deb, PhD, Sidney B Priesmeyer, Simone E Pitts, Siv K Si, Soyinka S Eneng, State Agency, Steven C Clifford, Steven D Kehoe, Steven P Allen, Steven P Donald, Stroman, Susan D Yuscius, Susan F Laska, MS, Susan M Jackson, Susanna E Ford, Analyst, Tamara J Genetti, Tamara J Umscheid, Tammy L Smith, Tara L Breckenridge, Tara L Greene, Tara L King, Teresa S Johnson, Theressa B Smith, Thomas J Arista, Thuy T Nguyen, LCDR, Tiara Nbrown Crosen, Torrey M Ward, Traci C Kelm, Tristian E Strait, Vaishali J Patel, Verlinda A Narcisse, Veronica Fuentes, MS, Vickie J Kanion, Victoria A Wagoner, Viviana Matta, Walden H Lee, Walsworth, Warren J Lopicka, Wayne D Mcgrath, Weston K Szymanski, William C Corley, William F Lagud, Jr, William J Leonard, Xikui Chen (nmi), PhD, Yaodong Huang, Yiyue Zhang (nmi), PhD, Zachary A Bogorad, Zhihao Qiu (Peter), PhD, Zhong Li, PhD, Zi Qiang Gu

Joseph R Lambert's Documents

Publish Date Document Type Title
November, 2012 EIR ALI Pharmaceutical Manufacturing, LLC - EIR, 2012-11-19
January, 2015 EIR Royal Canin USA, Inc. - EIR, 2015-01-21
May, 2012 EIR Hospira, Inc. - EIR, 2012-05-25
January, 2015 FDA 483 Royal Canin USA, Inc. - Form 483, 2015-01-21
July, 2015 EIR ProPharma Group, LLC DBA PI ARM - EIR, 2015-07-15
January, 2014 FDA 483 Marianna Industries, Inc - Form 483, 2014-01-09
November, 2008 FDA 483 Strategic Veterinary Pharmaceuticals, Inc. - Form 483, 2008-11-06
February, 2013 FDA 483 GSK Consumer Health, Inc. - Form 483, 2013-02-14
March, 2015 FDA 483 Quality Animal Care Mfg Inc - Form 483, 2015-03-25
December, 2015 FDA 483 Nebraska Methodist Hospital - Form 483, 2015-12-18
June, 2009 EIR TriRx Shawnee LLC - EIR, 2009-06-17
March, 2013 EIR Royal Canin USA, Inc. - EIR, 2013-03-27
November, 2008 EIR Strategic Veterinary Pharmaceuticals, Inc. - EIR, 2008-11-06
June, 2013 EIR Apotheca Company - EIR, 2013-06-19
July, 2011 FDA 483 Response GSK Consumer Health, Inc. - Form 483R, 2011-07-29
June, 2012 EIR LLOYD, Inc. of Iowa - EIR, 2012-06-15
May, 2015 FDA 483 Essential Pharmacy Compounding - Form 483, 2015-05-22
November, 2011 EIR Aspen API Inc. - EIR, 2011-11-02
February, 2010 FDA 483 EPM Packaging Inc - Form 483, 2010-02-04
February, 2015 EIR United Biosource Corp - EIR, 2015-02-19
June, 2009 FDA 483 TriRx Shawnee LLC - Form 483, 2009-06-17
March, 2010 FDA 483 LLOYD, Inc. of Iowa - Form 483, 2010-03-12
August, 2010 EIR Centrum Valley Farms LLP - EIR, 2010-08-30
December, 2014 FDA 483 New Dawn Nutrition, LLC - Form 483, 2014-12-30
April, 2010 FDA 483 GSK Consumer Health, Inc. - Form 483, 2010-04-16
March, 2010 FDA 483 ALI Pharmaceutical Manufacturing, LLC - Form 483, 2010-03-29
August, 2009 FDA 483 Univar USA, Inc. - Form 483, 2009-08-26
September, 2015 EIR ALI Pharmaceutical Manufacturing, LLC - EIR, 2015-09-04
February, 2009 FDA 483 Kv Pharmaceutical Inc - Form 483, 2009-02-02
February, 2013 EIR Patheon Italia S.p.A. - EIR, 2013-02-21
March, 2010 EIR ALI Pharmaceutical Manufacturing, LLC - EIR, 2010-03-29
February, 2014 FDA 483 UIHC-PET Imaging Center - Form 483, 2014-02-26
July, 2011 FDA 483 GSK Consumer Health, Inc. - Form 483, 2011-07-08
June, 2012 FDA 483 LLOYD, Inc. of Iowa - Form 483, 2012-06-15
March, 2011 FDA 483 Apotheca Company - Form 483, 2011-03-25
June, 2013 FDA 483 Apotheca Company - Form 483, 2013-06-19

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more